Neurobiology of Aging
Volume 30, Issue 9 , Pages 1379-1392 , September 2009

Amyloid-β precursor protein mediates neuronal toxicity of amyloid β through Go protein activation

  • Francisco Sola Vigo

      Affiliations

    • Instituto de Investigación Médica “Mercedes y Martín Ferreyra” - CONICET, Casilla de Correo 389, 5000 Córdoba, Argentina
  • ,
  • Gabriela Kedikian

      Affiliations

    • Instituto de Investigación Médica “Mercedes y Martín Ferreyra” - CONICET, Casilla de Correo 389, 5000 Córdoba, Argentina
  • ,
  • Lorena Heredia

      Affiliations

    • Instituto de Investigación Médica “Mercedes y Martín Ferreyra” - CONICET, Casilla de Correo 389, 5000 Córdoba, Argentina
  • ,
  • Florencia Heredia

      Affiliations

    • Instituto de Investigación Médica “Mercedes y Martín Ferreyra” - CONICET, Casilla de Correo 389, 5000 Córdoba, Argentina
  • ,
  • Alberto Díaz Añel

      Affiliations

    • Instituto de Investigación Médica “Mercedes y Martín Ferreyra” - CONICET, Casilla de Correo 389, 5000 Córdoba, Argentina
  • ,
  • Alberto Luis Rosa

      Affiliations

    • Instituto de Investigación Médica “Mercedes y Martín Ferreyra” - CONICET, Casilla de Correo 389, 5000 Córdoba, Argentina
    • Present address: Laboratorio de Biología Celular y Molecular, Fundación Allende, Hipólito Yrigoyen 384, Córdoba, Argentina.
  • ,
  • Alfredo Lorenzo

      Affiliations

    • Instituto de Investigación Médica “Mercedes y Martín Ferreyra” - CONICET, Casilla de Correo 389, 5000 Córdoba, Argentina
    • Departamento de Farmacología, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina
    • Corresponding Author InformationCorresponding author. Tel.: +54 351 468 1466; fax: +54 351 469 5163.

Received 27 August 2007 ,Revised 25 October 2007 ,Accepted 16 November 2007.

References 

  1. Arrasate M, Mitra S, Schweitzer E, Segal M, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431(7010):805–810
  2. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant Presenilin 1 and amyloid precursor proteins. Neuron. 1997;19:939–945
  3. Brouillet E, Trembleau A, Galanaud D, Volovitch M, Bouillot C, Valenza C, et al. The amyloid precursor protein interacts with Go heterotrimeric protein within a cell compartment specialized in signal transduction. J. Neurosci. 1999;19(5):1717–1727
  4. Busciglio J, Lorenzo A, Yankner BA. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging. 1992;13:609–612
  5. Busciglio J, Lorenzo A, Yeh J, Yankner BA. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995;14:879–888
  6. Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 1991;88(17):7552–7556
  7. Davis-Salinas J, Saporito-Irwin SM, Cotman CW, Van Nostrand WE. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 1995;65:931–934
  8. Deshpande A, Mina E, Glabe C, Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 2006;26(22):6011–6018
  9. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 1996;382(6593):716–719
  10. Galvan V, Gorostiza OF, Banwait S, Ataie M, Lonvinova AV, Sitaraman S, et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc. Natl. Acad. Sci. U.S.A. 2006;103(18):7130–7135
  11. Giambarella U, Yamatsuji T, Okamoto T, Matsuji T, Ikezu T, Murayama Y, et al. G protein betagamma complex-mediated apoptosis by familial Alzheimer's disease mutant of APP. EMBO J. 1997;16(16):4897–4907
  12. Grace E, Busciglio J. Aberrant activation of focal adhesion proteins mediates fibrillar amyloid β-induced neuronal dystrophy. J. Neurosci. 2003;23:493–502
  13. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356
  14. Hashimoto Y, Chiba T, Yamada M, Nawa M, Kanekura K, Suzuki H, et al. Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein. Mol. Cell. Biol. 2005;25(21):9304–9317
  15. Hashimoto Y, Niikura T, Ito Y, Nishimoto I. Multiple mechanisms underlie neurotoxicity by different types of Alzheimeŕs disease mutations of amyloid precursor protein. J. Biol. Chem. 2000;275(44):34541–34551
  16. Hashimoto Y, Tsuji O, Niikura T, Yamagishi Y, Ishizaka M, Kawasumi M, et al. Involvement of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death. J. Neurochem. 2003;84:864–877
  17. Heredia L, Helguera P, de Olmos S, Kedikian G, Solá Vigo F, Lamerla F, et al. Phosphorylation of ADF/Cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimeŕs disease. J. Neurosci. 2006;26(24):6533–6542
  18. Heredia L, Lin R, Solá Vigo F, Kedikian G, Busciglio J, Lorenzo A. Amyloid beta-induced neurodegeneration promotes cell surface accumulation of amyloid-beta precursor protein. Neurobiol. Dis. 2004;16(3):617–629
  19. Kayed R, Head E, Thopson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486–489
  20. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 1998;95(11):6448–6453
  21. Lorenzo A, Yankner BA. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. U.S.A. 1994;91:12243–12247
  22. Lorenzo A, Yuan M, Zhang Z, Paganetti P, Sturchler-Pierrat C, Staufenbiel M, et al. Amyloid beta interacts with amyloid precursor protein: a potential toxic mechanism in Alzheimeŕs disease. Nat. Neurosci. 2000;3:460–464
  23. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, et al. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat. Med. 2000;6(4):397–404
  24. Lu DC, Shaked GM, Masliah E, Bredesen DE, Koo EH. Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. Ann. Neurol. 2003;54:781–789
  25. Lu DC, Soriano S, Bredesen DE, Koo EH. Caspase cleavage of the amyloid precursor protein modulates amyloid β-protein toxicity. J. Neurochem. 2003;87:733–741
  26. McPhie DL, Coopersmith R, Hines-Peralta A, Chen Y, Ivins KJ, Manly SP, et al. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J. Neurosci. 2003;23(17):6914–6927
  27. Mendoza-Naranjo A, Gonzalez-Billault C, Maccioni R. Abeta1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. J. Cell Sci. 2007;120:279–288
  28. Nishimoto I, Okamoto T, Matsuura Y, Takahashi S, Okamoto T, Maruyama Y, et al. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go. Nature. 1993;362:75–79
  29. Ohgami T, Kitamoto T, Tateishi J. Alzheimer's amyloid precursor protein accumulates within axonal swellings in human brain lesions. Neurosci. Lett. 1992;136(1):75–78
  30. Pike CJ, Burduick D, Walancewicz A, Glabe CG, Cotman CW. In vitro aging of beta amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 1991;563:311–314
  31. Rohn TT, Ivins KJ, Bahr BA, Cotman CW, Cribbs DH. A monoclonal antibody to amyloid precursor protein induces neuronal apoptosis. J. Neurochem. 2000;74:2331–2342
  32. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet. 2006;38(1):24–26
  33. Russo T, Faraonio R, Minopoli G, De Candia P, De Renzis S, Zambrano N. Fe65 and the protein network centered around the cytosolic domain of the Alzheimeŕs beta-amyloid precursor protein. FEBS Lett. 1998;434:1–7
  34. Rymer DL, Goog TA. The role of G protein activation in the toxicity of amyloidogenic Abeta-(1–40), Abeta-(25–35), and bovine calcitonin. J. Biol. Chem. 2001;276(4):2523–2530
  35. Saganich MJ, Schroeder BE, Galvan V, Bredesen DE, Koo EH, Heinemann SF. Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J. Neurosci. 2006;26(52):13428–13436
  36. Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, et al. Increased APP expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006;51(1):29–42
  37. Schubert D, Behl C. The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix.. Brain Res. 1993;629(2):275–282
  38. Selkoe D. Alzheimer's disease: genes, proteins and therapy. Physiol. Rev. 2001;81:741–766
  39. Shaked GM, Kummer MP, Lu DC, Galvan V, Bredesen DE, Koo EH. Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597–624). FASEB J. 2006;20(8):1254–1256
  40. Sudo H, Jiang H, Yasukawa T, Hashimoto Y, Niikura T, Kawasumi M, et al. Antibody-regulated neurotoxic function of cell-surface beta amyloid precursor protein. Mol. Cell. Neurosci. 2000;16:708–723
  41. Taussig R, Sanchez S, Rifo M, Gilman AG, Belardetti . Inhibition of the omega-conotoxin-sensitive calcium current by distinct G proteins. Neuron. 1992;8(4):799–809
  42. Tsukamoto E, Hashimoto Y, Kanekura K, Niikura T, Aiso S, Nishimoto I. Characterization of the toxic mechanism triggered by Alzheimer's Amyloid beta peptides via p75 neurotrophin receptor in neuronal hybrid cells. J. Neurosci. Res. 2003;73:627–636
  43. Uetsuki T, Takemoto K, Nishimura I, Okamoto M, Niinobe M, Momoi T, et al. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J. Neurosci. 1999;19(16):6955–6964
  44. Van Nostrand WE, Melchor J, Keane D, Saporito-Irwin S, Romanov G, Davis J, et al. Localization of a fibrillar amyloid beta-protein binding domain on its precursor. J. Biol. Chem. 2002;277(27):36392–36398
  45. Wang HY, Lee DH, D’Andrea MR, Peterson PA, Shank RP, Reitz AB. Beta-Amyloid(1–42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 2000;275(8):5626–5632
  46. Wei W, Wang X, Kusiak JW. Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 2002;277(20):17649–17656
  47. White A, Maher F, Brazier M, Jobling M, Thyer J, Stewart L, et al. Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid-like protein 2 resulting in cellular accumulation.. Brain Res. 2003;966:231–244
  48. Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J. Clin. Invest. 1997;100(9):2333–2340
  49. Yamatsuji T, Matsui T, Okamoto T, Komatsuzaki K, Takeda S, Fukumoto H, et al. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimeŕs disease-associated mutants of APP. Science. 1996;272:1349–1352
  50. Yan SD, Chen X, Chen M, Zhu H, Roher A, Slattery T, et al. RAGE and Abeta peptide neurotoxicity in Alzheimer's disease. Nature. 1996;382:685–691
  51. Zheng H, Koo E. The amyloid precursor protein: beyond amyloid. Mol. Neurodegener. 2006;1:5

PII: S0197-4580(07)00450-2

doi: 10.1016/j.neurobiolaging.2007.11.017

Neurobiology of Aging
Volume 30, Issue 9 , Pages 1379-1392 , September 2009